Aurobindo Pharma Ltd has received US FDA approval for its Ciprofloxacin tablets in strengths 250, 500 and 750mg. Ciprofloxacin belongs to the class of floroquinolones. It is the generic international name for the synthetic microbicide manufactured and sold by Bayer Pharmaceutical under the brand names cipro, ciproxin and ciprobay. The product enjoys a market of over $230 million in the USA.

Ciprofloxacin is considered a yardstick with which the other quinolones efficacies are measured against. It is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria. It is used in lower respiratory infections (pneumonias), urinary tract infections, STDs, septicemias, Legionellosis and in some atypicals.